Intriguingly, the activation of GSDMD led to the development of CRC, while its inactivation was linked to an increased number of macrophages and reduced infiltration of immature myeloid cells, suggesting the potential use of NLRP3 inhibitors to counteract tumorigenesis [281]. The gene discussed is NLRP3; the disease is colorectal carcinoma.